NEW YORK (GenomeWeb) – Plant Bioscience Limited announced today that it has granted a worldwide, non-exclusive license to a series of RNAi-related patents to Thermo Fischer Scientific for use with its research reagents and kits.

The deal specifically covers nine US patents related to small RNA-triggered post-transcriptional gene silencing and based on the plant work of Sainsbury Laboratory researchers David Baulcombe and Andrew Hamilton. 

Financial terms of the arrangement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.